Showing results (621-630 of 1,042) with videos related to
Sort By:
Pageof 105
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 15, 2013
A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatmentCarolyn Miller Reilly, Deborah Watkins Bruner, Sandra A Mitchell, et al.Journal of Psychosocial Oncology|April 1, 2021
Symptom and needs assessment screening in oncology patients: Alternate outreach methods during COVID-19Kristina Davis, Kayla Wilbur, Susan Metzger, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2020
A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple SclerosisLouis S Matza, Glenn Phillips, Barry Dewitt, et al.Annals of Palliative Medicine|February 5, 2016
Do patients with brain metastases selected for whole brain radiotherapy have worse baseline quality of life as compared to those for radiosurgery or neurosurgery (with or without whole brain radiotherapy)?Ronald Chow, May Tsao, Natalie Pulenzas, et al.The Lancet. Oncology|August 9, 2014
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trialKarim Fizazi, Howard I Scher, Kurt Miller, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 21, 2014
Development of a symptom index for patients with primary brain tumorsJin-Shei Lai, Sally E Jensen, Jennifer L Beaumont, et al.Journal of Pain and Symptom Management|September 29, 2012
Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22)Timothy P Pearman, Jennifer L Beaumont, Diane Paul, et al.Cancer|March 23, 2016
Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinomaJennifer L Beaumont, John M Salsman, Jose Diaz, et al.The Journal of Supportive Oncology|October 20, 2007
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstrationKimberly Davis, Susan Yount, Katie Del Ciello, et al.Journal of Clinical Epidemiology|October 27, 2004
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scaleDavid T Eton, David Cella, Kathleen J Yost, et al.Pageof 105